OpenCitations

Works that cite this article, indexed by OpenCitations.

23 resultsUpdated October 20, 2026

← Back to article

Organoid models in viral hepatitis, primary liver cancer, and non-alcoholic fatty liver disease: Advances and challenges

Hepatobiliary & Pancreatic Diseases International 25(2) (2026)

Ya-Qin Han; Yun-Yang Xu; Ze Xiang; Qiu-Fang Xu; Fei Gao; Mei-Na Yan; Jian Wu

Down-regulation of suppressor of cytokine signaling 3 by miR-122 enhances interferon-mediated suppression of hepatitis B virus

Antiviral Research 118 (2015)

Dongni Gao; Aixia Zhai; Jun Qian; Aimei Li; Yujun Li; Wuqi Song; Hong Zhao; Xin Yu; Jing Wu; Qingmeng Zhang; Wenping Kao; Lanlan Wei; Fengmin Zhang; Zhaohua Zhong

Regulation of gene expression by microRNA in HCV infection and HCV–mediated hepatocellular carcinoma

Virology Journal 11(1) (2014)

Priyanka Gupta; Murray J Cairns; Nitin K Saksena

Toll like receptor (TLR)-induced differential expression of microRNAs (MiRs) and immune response against infection: A systematic review

Journal of Infection 67(4) (2013)

Seyed Hossein Aalaei-andabili; Nima Rezaei

MiR-221 accentuates IFN׳s anti-HCV effect by downregulating SOCS1 and SOCS3

Virology 462-463 (2014)

Gang Xu; Fang Yang; Cui-Ling Ding; Jing Wang; Ping Zhao; Wen Wang; Hao Ren

Can tobacco use promote HCV-induced miR-122 hijacking and hepatocarcinogenesis?

Medical Hypotheses 80(2) (2013)

Lijun Zhao; Farong Li; Ethan Will Taylor

Serum exosomal microRNA‑122 and microRNA‑21 as predictive biomarkers in transarterial chemoembolization‑treated hepatocellular carcinoma patients

Oncology Letters (2018)

Tomoyuki Suehiro; Hisamitsu Miyaaki; Yasuko Kanda; Hidetaka Shibata; Takuya Honda; Eisuke Ozawa; Satoshi Miuma; Naota Taura; Kazuhiko Nakao

Interplay of Wnt β-catenin pathway and miRNAs in HBV pathogenesis leading to HCC

Clinics and Research in Hepatology and Gastroenterology 43(4) (2019)

Muhammad Adeel Rana; Bushra Ijaz; Muhammad Daud; Sommyya Tariq; Tariq Nadeem; Tayyab Husnain

Nanoparticle Delivery of miR-122 Inhibits Colorectal Cancer Liver Metastasis

Cancer Research 82(1) (2022)

Hossein Sendi; Mostafa Yazdimamaghani; Mengying Hu; Nikhila Sultanpuram; Jie Wang; Amber S. Moody; Ellie McCabe; Jiajie Zhang; Amanda Graboski; Liantao Li; Juan D. Rojas; Paul A. Dayton; Leaf Huang; Andrew Z. Wang

The miR-122 inhibition alleviates lipid accumulation and inflammation in NAFLD cell model

Archives of Physiology and Biochemistry 127(5) (2019)

Yiyi Hu; Guoping Du; Guohua Li; Xuetao Peng; Zhiqiao Zhang; Yingji Zhai

miR-122 inhibition in a human liver organoid model leads to liver inflammation, necrosis, steatofibrosis and dysregulated insulin signaling

PLOS ONE 13(7) (2018)

Hossein Sendi; Ivy Mead; Meimei Wan; Marjan Mehrab-Mohseni; Kenneth Koch; Anthony Atala; Herbert L. Bonkovsky; Colin E. Bishop

Downregulation of microRNA-122 promotes proliferation, migration, and invasion of human hepatocellular carcinoma cells by activating epithelial–mesenchymal transition

OncoTargets and Therapy (2016)

Qiong Wang; Nanyao Wang; Dong Shen; Xia Sun; Xiangming Cao; Dan Wu

Hepatic disease biomarkers and liver transplantation: what is the potential utility of microRNAs?

Expert Review of Gastroenterology & Hepatology 7(2) (2013)

Ricardo C Gehrau; Valeria R Mas; Daniel G Maluf

Antitumor function of microRNA-122 against hepatocellular carcinoma

Journal of Gastroenterology 49(4) (2014)

Kazuhiko Nakao; Hisamitsu Miyaaki; Tatsuki Ichikawa

miR‐122 decreases HCV entry into hepatocytes through binding to the 3′ UTR of OCLN mRNA

Liver International 35(4) (2014)

Hossein Sendi; Marjan Mehrab‐Mohseni; David M. Foureau; Sriparna Ghosh; Tracy L. Walling; Nury Steuerwald; Philippe J. Zamor; Keith J. Kaplan; Carl Jacobs; William A. Ahrens; Mark W. Russo; Mark G. Clemens; Laura W. Schrum; Herbert L. Bonkovsky